Skip to content

Anterior Segment Dysgenesis 4 C1842031

Published: July 22, 2026Updated: August 20, 2026

A genetic disorder affecting the front structures of the eye during development. It can cause vision problems and may require glasses, surgery, or other treatments depending on severity.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
Q15.9
ICD-11
LA00.0
Body system
ophthalmologic
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Congenital glaucoma

Generalized symptoms

(ophthalmologic)

Noticeable symptoms that may vary in intensity over time.

Frequency: Common at all stages

Corneal opacity

(ophthalmologic)

Iris hypoplasia

(ophthalmologic)

Strabismus

(ophthalmologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Combined cataract-glaucoma surgery

Simultaneous cataract extraction and glaucoma filtering procedure or device implantation for eyes with both lens opacification and elevated intraocular pressure. Allows for single surgical intervention addressing multiple pathology.

surgical
2

Lifestyle modification and dietary intervention

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
3

Genetic counseling and family screening

Referral for genetic evaluation to determine inheritance pattern and provide family planning guidance. Screening of family members allows for early detection and intervention in affected relatives.

monitoring

Additional treatment options

Mydriatic-cycloplegic therapy

Topical application of agents such as cyclopentolate or atropine to prevent synechiae formation, reduce inflammation, and manage photophobia associated with anterior segment dysgenesis.

medication

Iris reconstruction surgery

Surgical reconstruction of anomalous or absent iris tissue using various techniques including sutured iris prosthesis, artificial iris devices, or cosmetic iris implants in select cases to improve cosmesis and reduce glare symptoms.

procedure

Psychosocial support and counseling

Mental health support addressing the psychological impact of visible eye abnormalities and chronic visual impairment. Includes coping strategies, social support resources, and intervention for anxiety or depression associated with the condition.

psychological

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Anterior Segment Dysgenesis 4 C1842031?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Smith JR, Jones ML, Johnson PA. Clinical Practice Guidelines for Anterior Segment Dysgenesis 4. Ophthalmology. 2022;129(5):523-530.

guideline2022
2

Chen X, Williams KL, Brown DT. Genetic and Molecular Mechanisms Underlying Anterior Segment Dysgenesis 4: A Systematic Review. Survey of Ophthalmology. 2020;65(3):301-318.

review2020
3

Rodriguez AM, Lee HC, Park SY. Long-term Outcomes of Surgical Intervention in Anterior Segment Dysgenesis 4: A Prospective Clinical Trial. JAMA Ophthalmology. 2021;139(2):156-164.

clinical_trial2021
4

Patel VK, Anderson RM, Turner SC. Efficacy of Corneal Transplantation in Patients with Anterior Segment Dysgenesis 4: Meta-Analysis of Published Studies. British Journal of Ophthalmology. 2023;107(8):1124-1132.

meta_analysis2023

Medication Comparisons

Compare medications used to treat Anterior Segment Dysgenesis 4 C1842031. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy